Salesforce Inc (CRM)
Salesforce faces tough enterprise software backdrop heading into earnings, says UBS
Salesforce Inc (NYSE:CRM, XETRA:FOO) heads into its fiscal first quarter earnings report on May 27, with analysts at UBS pointing to a mixed demand environment for enterprise software and limited signs of near-term acceleration in bookings trends. UBS wrote recent channel checks with roughly 25 enterprise IT executives and partners suggest IT spending growth remains constrained, particularly for non-AI application software.
Salesforce Likely to Beat Q1 Earnings Estimates: Time to Buy the Stock?
CRM's Q1 performance is likely to have witnessed the benefits of continued digital transformation and the increasing adoption of generative AI-enabled solutions.
Does Salesforce (CRM) Have the Potential to Rally 53.21% as Wall Street Analysts Expect?
The mean of analysts' price targets for Salesforce (CRM) points to a 53.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The Best Tech Stocks to Buy Now On the Dip: CRM for Triple-Digit Upside?
Investors looking for deals, value, and potentially flat-out cheap technology stocks to buy right now might want to consider Salesforce (CRM) stock.
Here's How Much Traders Expect Salesforce Stock Could Move After Earnings
Salesforce is scheduled to report its latest quarterly earnings after the closing bell on Wednesday, with traders expecting a large move in the software maker's stock.
Salesforce (CRM) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Salesforce (CRM) closed at $176.44, marking a -2.03% move from the previous day.
CRM or ADYEY: Which Is the Better Value Stock Right Now?
Investors with an interest in Internet - Software stocks have likely encountered both Salesforce (CRM) and Adyen N.V. Unsponsored ADR (ADYEY).
Salesforce (CRM) Is Considered a Good Investment by Brokers: Is That True?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Wall Street's Insights Into Key Metrics Ahead of Salesforce (CRM) Q1 Earnings
Besides Wall Street's top-and-bottom-line estimates for Salesforce (CRM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended April 2026.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Computer and Technology Names
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Veeva Systems: AI Fears Look Overdone, The Selloff Creates An Opportunity
Veeva Systems (VEEV) is rated Buy, trading at multi-year lows despite robust 16% revenue growth, 44% non-GAAP margins, and conservative FY27 guidance. AI disruption fears are overstated for VEEV's FDA-regulated Development Cloud, which comprises 55% of revenue and remains highly defensible due to regulatory switching costs. Vault CRM migration is progressing, reducing Salesforce dependency and enhancing control over product roadmap and AI integration; CRM competition is real but not existential.
Salesforce rated ‘Underperform' by Bank of America on AI growth concerns
Salesforce Inc (NYSE:CRM, XETRA:FOO) received a reinstated ‘Underperform' rating and $160 price target from Bank of America, with the firm arguing the software company is facing an “AI-driven structural reset.” The bank's price target implies downside from current levels of about $178.
